ALX Oncology Holdings Inc. (ALXO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for ALX Oncology Holdings Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.60x | -0.65x | -3.98x | -3.71x | -10.38x | -75.09x |
| P/B Ratio | 2.33x | 0.77x | 3.37x | 1.74x | 2.39x | 7.99x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 2905.75x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 9.1% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -3694.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -3869.7% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -3676.9% |
| Liquidity | ||||||
| Current Ratio | 2.07x | 7.26x | 5.24x | 9.57x | 24.00x | 70.28x |
| Quick Ratio | 2.07x | 7.26x | 5.24x | 9.57x | 24.00x | 70.28x |
| Leverage | ||||||
| Debt/Equity | 0.20x | 0.15x | 0.09x | 0.04x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..